Abstract
Objectives: To discover significant differentially expressed genes (DEGs) in clear cell renal cell carcinoma (ccRCC) that might be unidentified by single microarray analysis. Methods: The effect sizes of five ccRCC microarray data sets were combined using a random-effects model. The most downregulated gene was validated in paired 80 ccRCC tissues by immunohistochemistry. Results: CDC14B was the most downregulated gene among 1,761 DEGs. CDC14B was strongly expressed in the apical proximal tubules in the nonneoplastic tissues, while it was completely absent in 10 (12.5%) of 80 or downregulated in 70 (87.5%) of 80 ccRCC cases. The complete loss of CDC14B correlated with high T stage (P = .038), advanced TNM stage (P = .027), tumor recurrence (P = .038), and shorter recurrence-free survival (P = .046) compared with the partial loss of CDC14B. Conclusions: Microarray meta-analysis is a useful tool for pathologists. CDC14B expression is downregulated in ccRCC, suggesting its role in renal carcinogenesis.
Original language | English |
---|---|
Pages (from-to) | 551-558 |
Number of pages | 8 |
Journal | American Journal of Clinical Pathology |
Volume | 141 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2014 Apr |
Keywords
- CDC14B
- Meta-analysis
- Microarray
- Renal cell carcinoma
ASJC Scopus subject areas
- Pathology and Forensic Medicine